Delivery Credit
Prototype purchasing credit through the pharmacy website, viewing the balance, topping up and receiving confirmation. Agree charges, refunds, accounting and family permissions before production.
Following feedback from drivers and the pharmacy, I would like to explore whether modern web, voice and AI technology could offer useful support alongside PharmDel. My delivery-driving experience and web development skills provide a starting point for these suggestions.
Any proposal would first need to be reviewed and approved by the pharmacist and pharmacy owner before development, a pilot or discussions committing the pharmacy to an integration. Any PharmDel connectivity would also require PharmDel’s agreement. Nothing has been agreed at this stage.
These suggestions follow feedback from drivers and the pharmacy and draw on my delivery-driving experience and web development skills. They are offered for discussion with PharmDel’s owners and the Mossley pharmacy team. The pharmacist and pharmacy owner would need to review and approve any proposal before it could proceed; no partnership, pilot or development plan has been agreed.
A suggested development sequence, not a claim that these services are already implemented. Build and test with fictional data before an authorised pilot.
Prototype purchasing credit through the pharmacy website, viewing the balance, topping up and receiving confirmation. Agree charges, refunds, accounting and family permissions before production.
Develop the two connected assistants together in one phase: accessible patient arrival updates, acknowledgements and verified charge information, alongside voice-led round help, relevant patient replies, package reminders, returns and operational summaries. Explore the smallest useful shared workflow in a fictional sandbox, then discuss a bounded pilot with the pharmacy and PharmDel.
Emulate round, status, next-delivery, ETA, instruction and charge events with fictional records. Validate the supplied protocol and exact permissions. Partner-approved production connectivity follows demonstrated behaviour.
Answer “Do I owe anything today?” from authoritative payment records. Measure acknowledgement, doorstep waiting, failed attempts and usability against a baseline. Benefits remain hypotheses to test.
Retain completed work for richer prescription information, history, payment, nominated collectors, preferences and pharmacy messages. The app is optional; web assistance comes first.
PharmDel manages the delivery operation. Patient Assist prepares and informs the patient. Driver Assist helps the driver through the round. The pharmacy website provides the patient-facing service and commercial layer.
ETA • voice-capable help • acknowledgement • charges • Delivery Credit
Voice-led round help • relevant patient replies • reminders • operational insights
Exchange only relevant delivery events. A separately authorised Titan adapter may support non-round services; this diagram does not confirm any production data access. The optional Patient App can later reuse these services.
Start with a fictional pharmacy, patient, delivery and charge. A sandbox can test the patient and driver experiences together without a live connection.
An authorised or simulated next-delivery event estimates arrival in 3 minutes. Only enabled patients receive the update.
“I’m coming to the door”, “I need a little longer”, “I won’t be available”, or “Do I have anything to pay?” Text and touch remain available.
“Patient acknowledged — may need additional time to reach the door.” Routine conversation stays with Patient Assist; exceptions go to pharmacy staff.
In the same proposed phase, Driver Assist would consume the shared contract and trigger eligible patient updates. Completion still comes from the authoritative delivery system.
Respect PharmDel’s existing delivery platform and confirm the supported scope of rounds, proof of delivery, optimisation, notifications, tracking, fleet, mileage, reporting and PMR integration.
Illustrative screens using fictional route and patient references. No API calls, real locations or live updates occur here.
“Grab the route” starts the discussion, but patient holds, shared journeys and delays require clear ownership and reconciliation.
| Interface proposal | Minimum useful information | Boundary to agree |
|---|---|---|
| Authorised route snapshot | Pharmacy/driver scope, route ID/version, stable stop/job references, sequence, approved navigation point, package count, relevant windows/policy flags. | Read-only starting scope. Confirm access, refresh, expiry, location necessity and permitted use. |
| Delivery events | Approved dispatch, status, delay and outcome events with time, source and stable references. | Patient notifications must be based on authorised data. An ETA is an estimate, not handover evidence. |
| Hold or combine request | Patient intent linked to their own prescription/parts. Pharmacy approval, request ID and expected route version. | Optional separate write/event channel. Reject stale/conflicting changes; return acknowledgement. A read export does not grant mutation access. |
| Reconciliation | Versioned refresh, applied/rejected result and unresolved changes visible to staff/driver. | Repeat requests must not duplicate actions. Avoid silent divergence between overlay and source round. |
| Handover evidence | Authorised outcome reference and suitable photo/evidence access if supported. | Agree evidence owner, storage, retention and viewer permissions; a photo alone cannot relax policy. |
The patient asks for one combined handover. The app records intent and acknowledges receipt, not approval.
Staff check urgency, policy and part readiness. Other household members’ deliveries remain separate.
Through an agreed change mechanism, check the current version, acknowledge the decision and refresh the round.
Review when safely stopped. Preserve custody/return tracking for the loaded part; update affected ETAs.
Read-only scoped route, reminders and notes. PharmDel remains the driver’s delivery platform. Minimal interface requirement first.
Launch patient-response or assistance views from an existing driver flow if the platform supports and approves it. Identity boundaries need explicit agreement.
Restricted driver login, checklist and live replies. Requires enough agreed route/status interoperability to avoid duplicated operational authority.
Let patients request repeats, understand split supply, prepare for arrival and view verified history. Voice/status reading is a future accessibility goal alongside touch and text.
Collection can use an authorised reference or QR/NFC and nominated-carer checks, with a staff-assisted fallback. The focus remains reliable customer delivery and collection.
Round locations, references and notes can identify people. A live pilot needs agreed roles, access scopes, retention and data-sharing arrangements. Avoid broad clinical access merely for navigation.
Distinguish measured, calculated, estimated and demo metrics. No savings or break-even claim is presented as proven.
Propose nopCommerce multi-store for pharmacy shops, with pharmacy-specific loyalty rules. Prepaid delivery credit would be a separate ledger from shop reward points.
Use a confirmed payment result, show the balance and issue a receipt. Define refunds and insufficient-credit handling.
Identify the authorised delivery transaction and confirm the agreed amount. Repeated scans/taps return the same result without another deduction.
Agree whether and how charge/receipt status is exchanged. A route interface does not imply payment capabilities; drivers do not invent charges or waivers.
What interfaces exist, which option fits PharmDel, and what would a bounded fictional proof need to show?
Validate the supplied protocol, fictional round events, identity and minimum data. Confirm exact PharmDel/Titan permissions and supported capabilities.
Prove the arrival message, acknowledgement, extra-time response and verified charge using fictional events. Include missing data, stale events and duplicate notification handling. Demonstrate Driver Assist alongside Patient Assist in the same phase.
Agree participants, safety/data arrangements, baseline measures and support. Proceed only after evidence and partner approval.
Tell us which boundary, interface or driver experience would be practical.